May 23, 2013
(Stock Blog Hub,
4/23/13)
Warner Chilcott plc (WCRX) recently received encouraging news from the US Food and Drug Administration (FDA) when the regulatory agency approved the...(read more)
(Robert Weinstein Trading Blog,
8/3/11)
Warner Chilcott Plc (WCRX) is a $16.17 billion market cap company that trades an average of 1.74 million shares per day. Analysts are expecting an improvement of $0.07 in earnings per share compared to last quarter's results of $0.82. The company was founded in [...]
(Stock Blog Hub,
7/1/11)
Warner Chilcott (WCRX) recently announced that there will be a change at the helm of its research & development (R&D) division from the...(read more)
Warner Chilcott (WCRX) Company Overview
There is no analysis for WCRX yet. But you can go to Wikinvest to help create one!
What's in this WCRX analysis on Wikinvest...
- Business Overview
- Business Economics
- Product Mix
- Market Segmentation
- Sources of Revenue
- Competition Measures
- Main Competitors
- SWOT Analysis
- Strengths
- Weaknesses
- Opportunities
- Threats
- Porter's Five Forces Analysis
- Threat of Entry of New Competitors: Low/Medium
- Threat of Substitute Products or Services: Low
- Bargaining Power of Customers: Medium/High
- Bargaining Power of Suppliers: Low
- Intensity of Competitive Rivalry: High
- Marketing Strategy
- Product
- Price
- Place
- Promotion
- Financial Metrics
- Profitability
- Return on Assets
- Return on Shareholder's Equity
- Net Profit Margin
- Efficiency
- Solvency and Leverage
- Operating Metrics
- Research and Development
- Legal Proceedings
- Other Notes
- Human Resources/Executive Compensation
- References